Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Seminars in Oncology|July 15, 2005
Pulmonary toxicity associated with the treatment of non-small cell lung cancer and the effects of cytoprotective strategiesRamesh Gopal
The Journal of Supportive Oncology|December 21, 2004
Non-small cell lung cancer: the role of cytoprotection in treating therapy-related toxicityRamesh Gopal
International Journal of Radiation Oncology, Biology, Physics|July 20, 2002
Plan space: representation of treatment plans in multidimensional spaceRamesh Gopal, George Starkschall
The Journal of Clinical and Aesthetic Dermatology|March 18, 2024
Integrating 40-GEP Testing to Improve Clinical Recommendations for Adjuvant Radiation for Cutaneous Squamous Cell Carcinoma: Multidisciplinary Consensus GuidelinesRamesh Gopal, Michael Marquardt, Gaurav Singh, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 20, 2015
Isolated port-site metastases after minimally invasive hysterectomy for endometrial cancer: outcomes of patients treated with radiotherapyJonathan Douglas Grant, Amit K Garg, Ramesh Gopal, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 2003
The relationship between local dose and loss of function for irradiated lungRamesh Gopal, Susan L Tucker, Ritsuko Komaki, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 2003
Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancerRamesh Gopal, George Starkschall, Susan L Tucker, et al.
Cancer|August 14, 2002
The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphomaBouthaina S Dabaja, Chul S Ha, Deborah A Thomas, et al.
International Journal of Radiation Oncology, Biology, Physics|October 10, 2022
Optimizing Preventive Adjuvant Linac-Based (OPAL) Radiation: A Phase 2 Trial of Daily Partial Breast IrradiationJay P Reddy, Xiudong Lei, Elizabeth S Bloom, et al.
JNCI Cancer Spectrum|November 9, 2023
A phase II clinical trial of frameless, fractionated stereotactic radiation therapy for brain metastasesAmit K Garg, Mike Hernandez, Pamela J Schlembach, et al.
Pageof 1